Abstract

Introduction: Diagnostic and management pathways for lentigo maligna (LM) are challenging, due to the risk of transformation into lentigo malignant melanoma (LMM) of 5–20%. Clinical guidance recommends excisional biopsies of 2–5 mm margins as gold standard. Consistency to this between different clinicians and specialties remains poor. We report our experience.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call